Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins

Blood

Volumn 97, Issue 11, 2001, Pages 3537-3543

  Mizuochi, Tsuguo ^a,b,c,d   Pastore, Yves ^a,b,c,d   Shikata, Kohdoh ^a,b,c,d   Kuroki, Aki ^a,b,c,d   Kikuchi, Shuichi ^a,b,c,d   Fulpius, Thierry ^a,b,c,d   Nakata, Munehiro ^a,b,c,d   Fossati Jimack, Liliane ^a,b,c,d   Reininger, Luc ^a,b,c,d   Matsushita, Misao ^a,b,c,d   Fujita, Teizo ^a,b,c,d   Izui, Shozo ^a,b,c,d,e  

^a TOKAI UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d INSERM   (France)

^e CMU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; GALACTOSE; IMMUNOGLOBULIN G3;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GEL FILTRATION; GLOMERULONEPHRITIS; KIDNEY DISEASE; MOUSE; MYELOMA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL;

EID: 0035383763     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3537     Document Type: Article

References (54)

1. Grey HM, Kohler PF. Cryoimmunoglobulins. Semin Hematol. 1973;10:87-112.
2. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med. 1974;57:775-788.
3. Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. J Immunol. 1987;138:3785-3792.
4. Abdelmoula M, Spertini F, Shibata T, et al. IgG3 is the major source of cryoglobulins in mice. J Immunol. 1989;143:526-532.
5. Spertini F, Coulie PG, Van Snick J, Davidson E, Lambert PH, Izui S. Inhibition of cryoprecipitation of murine IgG3 anti-dinitrophenyl (DNP) monoclonal antibodies by anionic DNP-amino acid conjugates. Eur J Immunol. 1989;19:273-278.
6. Panka DJ, Salant DJ, Jacobson BA, Minto AW, Marshak-Rothstein A. The effect of VH residues 6 and 23 on IgG3 cryoprecipitation and glomerular deposition. Eur J Immunol. 1995;25:279-284.
7. Lemoine R, Berney T, Shibata T, et al. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 1992;41:65-72.
8. Berney T, Fulpius T, Shibata T, et al. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol. 1992;4:93-99.
9. Takahashi S, Itoh J, Nose M, Ono M, Yamamoto T, Kyogoku M. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse. Mol Immunol. 1993;30:177-182.
10. Itoh J, Nose M, Takahashi S, et al. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Am J Pathol. 1993;143:1436-1443.
11. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci U S A. 1990;87: 10038-10042.
12. Izui S, Fulpius T, Reininger L, Pastore Y, Kobayakawa T. Role of neutrophils in murine cryoglobulinemia. Inflamm Res. 1998;47:S145-S150.
13. Moll S, Menoud PA, Fulpius T, et al. Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis. Kidney Int. 1995; 48:1459-1468.
14. Fulpius T, Spertini F, Reininger L, Izui S. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc Natl Acad Sci U S A. 1993;90:2345-2349.
15. Rengers JU, Touchard G, Decourt C, Deret S, Michel H, Cogné M. Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia. Blood. 2000;95:3467-3472.
16. Nose M, Wigzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A. 1983;80:6632-6636.
17. Wright A, Morrison SL. Effect of altered CH-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. J Exp Med. 1994; 180:1087-1096.
18. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316:452-457.
19. Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T. A comparative analysis of disease-associated changes in the glycosylation of serum IgG. J Autoimmun. 1989;2:101-114.
20. Mizuochi T, Hamako J, Nose M, Titani K. Structural changes in the oligosacchadde chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. J Immunol. 1990;145:1794-1796.
21. Bond A, Cooke A, Hay FC. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol. 1990;20:2229-2233.
22. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol. 1991;147:515-519.
23. Fossati L, Takahashi S, Merino R, et al. An MRL/ MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome. Int Immunol. 1993;5:525-532.
24. Takahashi S, Fossati L, Iwamoto M, et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest. 1996;97:1597- 1604.
25. Rademacher TW, Williams P, Dwek RA. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A. 1994;91:6123-6127.
26. Neuberger MS. Expression and regulation of immunoglobulin heavy gene transfected into lymphoid cells. EMBO J. 1983;2:1373-1378.
27. Wels JA, Word CJ, Rimm D, et al. Structural analysis of the murine IgG3 constant region gene. EMBO J. 1984;3:2041-2046.
28. Oi VT, Morrison SL, Herzenberg LA, Berg P. Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A. 1983; 80:825-829.
29. Orlandi R, Güssow DH, Jones PT, Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989;86:3833-3837.
30. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463-5467.
31. Kitamura D, Roses J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 1991;350:423-427.
32. Labit C, Pierres M. Rat monoclonal antibodies to mouse IgG1, IgG2a, IgG2b, and IgG3 subclasses, and kappa chain isotypic determinants. Hybridoma. 1984;3:163-169.
33. Reth M, Imanishi-Kari T, Rajewsky K. Analysis of the repertoire of anti-(4-hydroxy-3-nitrophenyl)acetyl antibodies in C57BL/6 mice by cell fusion. Eur J Immunol. 1979;9:1004-1013.
34. Spertini F, Donati Y, Welle I, Izui S, Lambert PH. Prevention of murine cryoglobulinemia and associated pathology by monoclonal anti-idiotypic antibody. J Immunol. 1989;143:2508-2513.
35. Mizuochi T, Taniguchi T, Shimizu A, Kobata A. Structural and numerical variations of the carbohydrate moiety of immunoglobulin. J Immunol. 1982;129:2016-2020.
36. Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosacchadde chains of human von Willebrand factor: occurrence of blood group A, B, and H(O) structures. J Biol Chem. 1992;267:8723-8731.
37. Mizuochi T. Microscale sequencing of N-linked oligosaccharides of glycoprotein using hydrolysis, Bio-Gel P-4, and sequential exoglycosidase. Methods Mol Biol. 1993;14:55-68.
38. Shikata K, Yasuda T, Takeuschi F, et al. Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconjugate J. 1998;15:683-689.
39. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med. 1992;176:1497-1502.
40. Mizuochi T, Loveless RW, Lawson AM, et al. A library of oligosaccharide probes (neoglycolipids) from N-glycosylated proteins reveals that conglutinin binds to certain complex-type as well as high mannose-type oligosaccharide chains. J Biol Chem. 1989;264:13834-13839.
41. Matsushita M, Endo Y, Taira S, et al. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J Biol Chem. 1996;271:2448-2454.
42. Cesari IM, Weigert M. Mouse lambda-chain sequences. Proc Natl Acad Sci U S A. 1973;70: 2112-2116.
43. Bothwell ALM, Paskind M, Reth M, Imanishi-Kari T, Rajewsky K, Baltimore D. Somatic variants of murine immunoglobulin λ light chains. Nature. 1982;298:380-382.
44. Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosacchadde. Nature. 1992; 360:127-134.
45. Dwek RA, Lellouch AC, Wormald MR. Glycobiology: the function of sugar in the IgG molecule. J Anat. 1995;187:279-292.
46. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995;1:237-243.
47. Panka DJ. Glycosylation is influential in murine IgG3 self-association. Mol Immunol. 1997;34: 593-598.
48. Fulpius T, Berney T, Lemoine R, et al. Glomerulopathy induced by IgG3 anti-trinitrophenyl monoclonal cryoglobulins derived from non-autoimmune mice. Kidney Int. 1994;45:962-971.
49. Grey HM, Hirst JW, Cohn M. A new mouse immunoglobulin: IgG3. J Exp Med. 1971;133:289-304.
50. Fulpius T, Lemoine R, Berney T, Pastore Y, Moll S, lzui S. Polymorphonuclear leukocytes play a key role in the generation of "wire-loop" lesions induced by a murine IgG3 rheumatoid factor. Kidney Int. 1996;49:647-655.
51. Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC, Roitt IM. Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet. 1987;2:1486-1488.
52. Furukawa K, Matsuta K, Takeuchi F, Kosuge E, Miyamoto T, Kobata A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int Immunol. 1990;2:105-112.
53. Axford JS, Alavi A, Bond A, Hay FC. Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis. Autoimmunity. 1994;17:157-163.
54. Jeddi PA, Bodman-Smith KB, Lund T, et al. Agalactosyl IgG and β-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse. Immunology. 1996;87:654-659.